InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX)
CUSIP: N44821101
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Shares, nominal value (euro)0.12 per share
- Shares outstanding
- 67,811,197
- Total 13F shares
- 3,501,150
- Share change
- -1,516,605
- Total reported value
- $16,070,000
- Put/Call ratio
- 694%
- Price per share
- $4.59
- Number of holders
- 34
- Value change
- -$6,253,771
- Number of buys
- 22
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP N44821101?
CUSIP N44821101 identifies IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N44821101:
Top shareholders of IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.6%
|
1,778,415
|
$6,794,000 | — | 31 Mar 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
1,067,600
|
$4,078,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.81%
|
551,274
|
$2,106,000 | — | 31 Mar 2020 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.55%
|
370,000
|
$1,413,000 | — | 31 Mar 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.39%
|
262,600
|
$1,003,000 | — | 31 Mar 2020 | |
| Eversept Partners, LP |
13F
|
Company |
0.29%
|
195,488
|
$746,764 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
145,902
|
$557,000 | — | 31 Mar 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.16%
|
110,000
|
$420,000 | — | 31 Mar 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.16%
|
106,805
|
$408,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
105,817
|
$404,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
90,443
|
$345,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
83,806
|
$320,000 | — | 31 Mar 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
43,783
|
$167,000 | — | 31 Mar 2020 | |
| Walleye Capital LLC |
13F
|
Company |
0.04%
|
27,380
|
$104,000 | — | 31 Mar 2020 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.03%
|
21,585
|
$82,000 | — | 31 Mar 2020 | |
| Spark Investment Management LLC |
13F
|
Company |
0.03%
|
18,800
|
$71,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
16,473
|
$63,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
10,445
|
$40,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
7,691
|
$29,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,385
|
$9,000 | — | 31 Mar 2020 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
800
|
$3,000 | — | 31 Mar 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
263
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q2 2020
As of 30 Jun 2020,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,501,150 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, MORGAN STANLEY, FNY Investment Advisers, LLC, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, Birchview Capital, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
22
Q2 2020 holders
34
Holder diff
12
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.